Moderna expects up to 10% 2026 revenue growth and $4.5B-$5B year-end cash, while targeting ~$4.2B cash costs (NASDAQ:MRNA)
ModernaModerna(US:MRNA) Seeking Alpha·2026-05-02 05:52

JavaScript与Cookie设置 - 为确保未来正常访问，用户需要在浏览器中启用JavaScript和cookie [1] 广告拦截器影响 - 如果用户启用了广告拦截器，可能会被阻止继续操作 [1] - 建议用户禁用广告拦截器并刷新页面以继续 [1]

Moderna expects up to 10% 2026 revenue growth and $4.5B-$5B year-end cash, while targeting ~$4.2B cash costs (NASDAQ:MRNA) - Reportify